The Board Relationship — Managing Up Without Losing Authority

Three-moment compound-pressure week as CEO Mateo Sandoval-Echeverría at NovaSano Therapeutics. Strategic disagreement with the science committee, succession trigger from the founder, and an activist crisis. Practice register-switching across the four-posture playbook (defend / defer / escalate / reframe), the surfacing-vs-reserving inventory with the chair, and the board-developed view in response to a Goldfinch Capital open letter.